DLA Piper has advised Arize AI. Goodwin has advised Dynatrace. Dynatrace, Inc. has entered into a definitive agreement to acquire Arize AI, a leading AI observability...
Dynatrace to Acquire Arize AI in $915 Million Cash and Stock Deal
Centerbridge Partners to Acquire MeridianLink in $2 Billion All-Cash Transaction
Kirkland & Ellis has advised Centerbridge Partners, and Goodwin Procter has advised MeridianLink. Skadden has advised Thoma Bravo, MeridianLink, Inc.’s largest shareholder. Paul Hastings LLP represented...
Generate:Biomedicines’ $273 Million Series C Funding Round
Goodwin advised Generate:Biomedicines on the fundraising. Generate:Biomedicines announced that it has raised $273 million in Series C financing. This financing round attracted many new investors including...
Dynatrace’s Acquisition of Rookout
Goodwin advised Dynatrace on the deal. Dynatrace (NYSE: DT) announced it has signed a definitive agreement to acquire Rookout. The addition of Rookout to the Dynatrace®...
Weaviate.io’s $50 Million Series B Funding Round
Goodwin Procter advised Weaviate.io on the deal. Weaviate.io announced its $50 million Series B funding round led by Index Ventures with participation from Battery Ventures. Weaviate’s existing...
PointClickCare’s Acquisition of Patient Pattern
Goodwin Procter advised PointClickCare Corp. on the deal. PointClickCare Corp. announced its acquisition of Patient Pattern. The combination of PointClickCare and Patient Pattern will further the companies’...
Thoma Bravo’s AUD $1.055 Billion Acquisition of Nearmap
Goodwin Procter advised Thoma Bravo on the deal. Thoma Bravo, a leading software investment firm, announced its definitive agreement to acquire 100% of the shares in...
Thoma Bravo’s $2.8 Billion Acquisition of Ping Identity
Kirkland & Ellis represented Ping Identity, while Goodwin Procter represented Thoma Bravo in the transaction. Ping Identity (NYSE: PING), provider of the Intelligent Identity solution for...
Thoma Bravo’s Acquisition of SailPoint Technologies Holdings
Kirkland & Ellis advised Thoma Bravo, while Goodwin Procter advised SailPoint Technologies Holdings, Inc. on the deal. Latham & Watkins represented the direct lenders in the...
Generate Biomedicines’ Research Collaboration Agreement with Amgen
Goodwin advised Generate Biomedicine on the deal. Generate Biomedicines announced its research collaboration agreement with Amgen (NASDAQ: AMGN) to discover and create protein therapeutics for five clinical...
Cint Group AB’s $1.07 Billion Acquisition of Lucid
Kirkland & Ellis and Gernandt & Danielsson advised Cint Group AB on the deal, while Goodwin Procter represented Lucid Holdings, LLC. Cint Group AB (publ), a...
Valo Health’s $2.8 Billion Merger with Khosla Ventures Acquisition Co.
Goodwin Procter LLP advised Valo Health on the deal, while Latham & Watkins LLP represented Khosla Ventures Acquisition Co. Valo Health announced its definitive merger agreement with...